Results 271 to 280 of about 255,512 (289)

Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance

Annual Review of Pathology: Mechanisms of Disease, 2021
Edgar G Engleman
exaly  

Immune-checkpoint inhibitors: long-term implications of toxicity

Nature Reviews Clinical Oncology, 2022
Douglas B Johnson, Msci, Justin M Balko
exaly  

Beyond immune checkpoint blockade: emerging immunological strategies

Nature Reviews Drug Discovery, 2021
Daniel Vilarim Araújo, Lillian L Siu, Tak W Mak   +2 more
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Conor Steuer, Taofeek Kunle Owonikoko   +2 more
exaly  

Tumour burden and efficacy of immune-checkpoint inhibitors

Nature Reviews Clinical Oncology, 2021
Aurelien Marabelle, Camilo Garcia, Mihaela Aldea   +2 more
exaly  

Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors

Nature Reviews Clinical Oncology, 2023
Richard A Scolyer, Georgina V Long
exaly  

Immune checkpoint inhibitors

Reactions Weekly, 2018
  +4 more sources

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

Nature Reviews Clinical Oncology, 2021
Mary Beth Beasley, Sacha Gnjatic, Ignacio I Wistuba   +2 more
exaly  

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

Nature Reviews Clinical Oncology, 2020
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué   +2 more
exaly